(NASDAQ: TELA) Tela Bio's forecast annual revenue growth rate of 22.42% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Tela Bio's revenue in 2025 is $69,300,000.On average, 2 Wall Street analysts forecast TELA's revenue for 2025 to be $3,369,753,550, with the lowest TELA revenue forecast at $3,353,933,110, and the highest TELA revenue forecast at $3,385,573,989. On average, 2 Wall Street analysts forecast TELA's revenue for 2026 to be $4,174,618,394, with the lowest TELA revenue forecast at $4,034,211,996, and the highest TELA revenue forecast at $4,315,024,792.
In 2027, TELA is forecast to generate $4,746,131,760 in revenue, with the lowest revenue forecast at $4,746,131,760 and the highest revenue forecast at $4,746,131,760.